Tokyo, May 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061702) titled 'Quantitative and Qualitative Evaluation of Burden among Formal Caregivers in Managing Agitation among Patients with Alzheimers Disease' on May 27.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceuticals Co., Ltd
Condition:
Condition - Altzheimer's disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to identify whether professional caregivers working in Japanese long-term care facilities experience caregiver burden when responding to agitation in patients with Alzheimer's dementia, as well as to clarify the extent of that burden. To achieve this, the study examines the conceptual framework for measuring such burden and quantitatively evaluates the burden experienced by professional caregivers using a questionnaire composed of appropriate psychological scales.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Individuals who are directly engaged in providing care to persons with dementia who are using long-term care services, or who have been engaged in such care within the past six months.
Individuals who have provided informed consent to participate in this study.
Key exclusion criteria - Including those whose workplace is a medical institution.
Target Size - 15
Recruitment Status:
Recruitment status - Suspended
Date of protocol fixation - 2025 Year 12 Month 04 Day
Date of IRB - 2025 Year 12 Month 17 Day
Anticipated trial start date - 2026 Year 01 Month 15 Day
Last follow-up date - 2027 Year 12 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070607
Disclaimer: Curated by HT Syndication.
